QA: Chinook Therapeutics INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001435049_2017_Chinook_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001435049, Chinook Therapeutics INC

  xvar xval
0 AssetsCurrent 354,764,000
1 IntangibleAssetsNetIncludingGoodwill 35,485,000
2 PropertyPlantAndEquipmentNet 26,384,000
3 remainder_Assets 21,978,000
4 LiabilitiesCurrent 30,632,000
5 LiabilitiesNoncurrent 1,109,000
6 remainder_Liabilities 179,650,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 34,277,000
9 ResearchAndDevelopmentExpense 87,718,000
10 remainder_Expenses 22,013,000
11 remainder_Revenues 50,681,000
12 remainder_NetIncome 2,179,000
13 remainder_ComprehensiveNetIncome -1,345,000
  yvar yval
0 Assets 438,611,000
1 Liabilities 211,391,000
2 Expenses 144,008,000
3 Revenues 50,681,000
4 StockholdersEquity 227,220,000
5 NetIncome -91,148,000
6 ComprehensiveNetIncome -91,820,500
7 BaseVar 424,107,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.24
9 EconomicCapitalRatio 2.49

Edgar->Model Mapping

Feature Distribution

Change over Time